Company: NKLR
Filing Date: 2025-08-01
Form Type: S-4/A
Source: 0001213900-25-070223
Chunk: 185

Company: Terra Innovatum Global N.V.
Filing Date: 2025-08-01
Form: S-4/A
Chunk 185
---
 to use Terra Innovatum’s stock as an acquisition currency for potential opportunistic acquisitions in the future. Terra Innovatum opted to pursue de -SPACtransaction in lieu of a traditional initial public offering given the prevalence of de -SPACtransactions in the nuclear reactor sector. On November 21, 2024, GSR III held an introductory meeting over Zoom with Terra Innovatum and PAC. During the meeting, representatives of Terra Innovatum presented on Terra Innovatum’s history, management team and business opportunities. In the evening, following the Zoom meeting, a representative of GSR III met in person with a subset of the Terra Innovatum team in New York. Subsequent to the meetings, GSR III sent an executed non -disclosureagreement to Terra Innovatum. On November 23, 2024, GSR III and Terra Innovatum agreed to a follow -upmeeting on November 27, 2024, where Terra Innovatum would continue its discussion of the Terra Innovatum business and Terra Innovatum’s positioning in the market relative to competitors, while GSR III would present to Terra Innovatum what a SPAC transaction would entail from a process, timeline and capitalization perspective. On November 24, 2024, representatives of Terra Innovatum requested to representatives of GSR III that, during the upcoming call, GSR III include a discussion of potential valuation, funding scenarios and governance. Representatives of Terra Innovatum also requested that representatives of GSR III consider a valuation of $1.1billion. On November 26, 2024, Terra Innovatum provided GSR III access to information in a data room. On November 27, 2024, GSR III, Terra Innovatum and PAC held a follow -upmeeting over Zoom to continue discussing Terra Innovatum’s business, as well as GSR III presenting to Terra Innovatum what a SPAC transaction would entail. GSR III indicated it would need to perform a valuation analysis that was primarily based on a comparison to the three existing public SMR companies, and that GSR III would also require a fairness opinion from an independent third -partyvaluation firm before entering into a formal transaction with Terra Innovatum. On November 29, 2024, Terra Innovatum sent the counter -signedNDA to GSR III, as well as a list of questions that Terra Innovatum asked GSR III, including clarification on fees and expenses, as well as the impact of various potential fundraising strategies. On December 2, 2024,